Mesenchymal stem cells (MSCs) may be used as a cell source for cell therapy of solid organs due to their differentiation potential and paracrine effect. Nevertheless, optimization of MSC-based therapy needs to develop alternative strategies to improve cell administration and efficiency. One option is the use of alginate microencapsulation, which presents an excellent biocompatibility and an in vivo stability. As MSCs are hypoimmunogenic, it was conceivable to produce microparticles with [alginate-poly-L-lysine-alginate (APA) microcapsules] or without (alginate microspheres) a surrounding protective membrane. Therefore, the aim of this study was to determine the most suitable microparticles to encapsulate MSCs for engraftment on solid organ. First, we compared the two types of microparticles with 4 × 10 6 MSCs/ml of alginate. Results showed that each microparticle has distinct morphology and mechanical resistance but both remained stable over time. However, as MSCs exhibited a better viability in microspheres than in microcapsules, the study was pursued with microspheres. We demonstrated that viable MSCs were still able to produce the paracrine factor bFGF and did not present any chondrogenic or osteogenic differentiation, processes sometimes reported with the use of polymers. We then proved that microspheres could be implanted under the renal capsule without degradation with time or inducing impairment of renal function. In conclusion, these microspheres behave as an implantable scaffold whose biological and functional properties could be adapted to fit with clinical applications.
INTRODUCTION
A way to protect MSCs and take advantage of their paracrine properties could be their inclusion in a biomatrix. This could permit to 1) prevent mechanical stress, Mesenchymal stem cells (MSCs) are multipotent stem cells derived from bone marrow stroma. They have 2) diminish the negative influence of the injured environment on grafted cells, 3) easily manipulate and de-the ability to form a variety of mesenchymal tissues including bone, fat, and cartilage, and non-mesenchymal liver the cells near the organ, and 4) better follow the phenotype of the grafted cells. This goal may be tissues like neuron, kidney, and heart (13, 15, 27, 36, 55) . Recent studies have shown that most of the therapeutic achieved through the microencapsulation of MSCs in biomatrices and implantation of this scaffold. The de-effects of MSCs are related to the secretion of paracrine factors (17, 47) . Systemic administration is easy but there sign of the microparticles has to be optimized for permeability, stability, biocompatibility, and easiness of injec-is little quantity of cells reaching the organ. These findings supported the idea that direct intraparenchymal in-tion and integration. The advantage of natural polymers in comparison to synthetic polymers is that they induce jection would allow to concentrate the paracrine factors produced by MSCs within the injured organ. However, less cytotoxicity or inflammatory reactions (21) . Alginate is the most commonly employed polymer the intraparenchymal administration is characterized by early death of grafted cells (23, 29, 38, 44, 48) and in the for cell encapsulation because of its excellent biocompatibility and an in vivo stability (6, 40, 53) . Alginate is case of their survival they potentially differentiate in unsuitable phenotypes. a polysaccharide isolated from brown algae found in coastal waters around the globe (19) . It is a linear copol-were able to differentiate into cells from mesodermal lineage: osteoblasts, chondrocytes, and adipocytes (data ymer composed of β-D-mannuronic acid and α-L-guluronic acid that can be easily transformed into a gel by not show). binding the guluronic acids with a divalent cation such MSC Encapsulation as calcium (41) . Classically, cells are encapsulated in alginate microcapsules with a semipermeable mem-Rat MSCs (passage 3) were lifted with trypsin, counted, and centrifuged. Microspheres and microcapsules brane, generally polylysine (PLL), which allows nonautologous cells to be implanted. This membrane protects were produced by the method of Goosen et al. with modifications (10) under sterile conditions. We used the cells from immune mediators and allows the release of beneficial factors from the microcapsule.
sterile ultrapur sodium alginate with 54% β-D-mannuronic acid (type M alginate) with an apparent viscosity of Previous results from our laboratory have shown that adrenal medullary bovine chromaffin cells could be en-141 mPas.s (Pronova, SLM 100, Novamatrix, Norway). Briefly, a 1.4% w/v sodium alginate solution was pre-capsulated in microcapsules of alginate-poly-L-lysine (APA) with a liquefied inner core (28). This procedure pared by dispersing alginate in NaCl 150 mM, buffered to pH 7.4 with 12.5 mM HEPES. Cells were resus-was associated to an increase in the viability of functional cells. However, in clinical applications of MSCs, pended in this sodium alginate solution at a density of 2.5 × 10 6 or 4 × 10 6 cells/ml alginate. Homogeneous a semipermeable membrane may not be necessary as these cells are poorly immunogenic (1, 7, 16, 49) . We hy-alginate microspheres were produced by extruding through an encapsulator (Inotech IE-50R, Switzerland), pothesized that alginate microspheres could also be suitable for MSC encapsulation. However, little is known equipped with a 300-µm vibrating nozzle, the alginatecell suspension into a solution of 1% CaCl 2 , 2H 2 O, 0.4% concerning viability and functionality of MSCs in microspheres. In addition, the use of alginate microsphere NaCl, 12.5 mM HEPES, pH 7.4, which was continuously swirled. Microspheres were gelled for at least 20 graft for cell therapy of solids organs has not been extensively investigated. Indeed, microspheres present dif-min and then rinsed with HEPES buffer and either transferred into culture medium (case of alginate micro-ferent permeability and mechanical behavior than microcapsules that could consequently impact the implantation spheres) or coated by incubating in 0.1% w/v PLL, 150 mM NaCl, 12.5 mM HEPES, pH 7.4, under gentle agita-procedure and in vivo scaffold integrity.
Thus, we designed a strategy based on the encapsula-tion. In the latter case, an outer alginate layer was subsequently applied by 10-min incubation in a dilute (0.1% tion of MSCs in alginate microspheres or microcapsules in order to determine which one was the most appro-w/v) alginate solution in saline buffer under gentle agitation (case of APA microcapsules). Finally, microcap-priated for cell therapy. We first evaluated the stability and mechanical parameters of microparticles. We then sules were treated with 55 mM sodium citrate to liquefy the inner alginate core, and washed extensively with sa-tested MSC viability and functionality in microparticles. We also determined the effect of alginate on differentia-line buffer. Both types of microparticles-microspheres and microcapsules-were studied. tion of MSCs. Finally, we studied the feasibility of grafting alginate-encapsulated MSCs under the rat renal cap-Microspheres and microcapsules were incubated in culture medium at 37°C in 5% CO 2 and 95% humidity. sule.
At specified days postencapsulation, they were collected MATERIALS AND METHODS and further analyzed. In order to characterize their mor-Cell Culture phology and properties, control microparticles (without cells) were also prepared according to the same protocol. Marrow aspirate was obtained from femurs cavity of Lewis rats (Harlan, France) weighing 180-200 g. Bone
Morphology and Stability of Particles Over Time marrow from the femur cavity was flushed with MEM medium (ABCYs, France) containing 10% FCS and 1%
Size and morphology of microparticles were routinely examined with a light microscope. The stability penicillin/streptomycin (Invitrogen, USA) and the cell suspension was centrifuged (400 × g, 5 min). Then, cells of control microparticles was studied for 35 days at 37°C in saline buffer both visually and by light micro-were plated in culture flasks (200,000 cells/cm 2 ). Nonadherent cells were removed after 72 h and MSCs were scopic observation. In the case of microcapsules, their integrity was assessed. recovered by their capacity to adhere highly to plastic culture dishes. MSCs were then routinely cultured and Scanning Electron Microscopy (SEM) were used for the experiments. Most adherent cells expressed MSC markers CD90, CD29, and CD106 and SEM analysis of the surface and cross section of dried control microparticles was performed with a scan-were negative for CD34 (hematopoietic marker), CD45 (B cells marker), and CD31 (vascular cell marker). They ning electron microscope (Leo 435 VP). The microparti-cle samples were mounted on an aluminum sample branes were incubated to horseradish peroxidase-conjugated anti-rabbit secondary antibody (1:10,000; Santa mount and sputter coated with silver. The specimens were observed at a 10 kV accelerating voltage.
Cruz Biotechnology). Expression of bFGF is related to the expression of ERK2.
Mechanical Resistance
The mechanical resistance of the microparticles was Chondrogenic Phenotype of Encapsulated MSCs evaluated on microspheres or microcapsules obtained MSCs encapsulated in microspheres where cultured with a 0.8-mm needle according to the same protocol.
in high-glucose Dulbecco's modified Eagle's medium At defined time intervals, the microparticles were sub-(ABCYs, France) with 1% fetal bovine serum (Inmitted to a standardized compression test in a TA-XT2 vitrogen, USA), antibiotics, modified or not with ascortexture analyzer (Stable Microsystems, UK). Briefly, the bate-2-phosphate (50 µg/ml, Sigma, France), proline (40 compression resistance of the microparticles was deterµg/ml, Sigma), pyruvate (3 mM, Sigma), ITS+ (1×, BD mined as the main force (g) required to generate a 30% Biosciences, USA), dexamethasone (100 mM, Sigma), compression of a sample of microparticles. The apparatransforming growth factor-β3 (10 ng/ml, TGF-β3, tus consisted of a mobile probe moving vertically, up R&D Systems, USA), and recombinant bone morphoand down at constant and predefined velocity (0.5 mm/ genic protein-2 (200 ng/ml, R&D Systems). Medium s). The force exerted by the probe on the microparticles was replaced twice weekly. On day 21, 31, 51, 57, and was recorded as a function of the displacement, leading 61, MSCs were harvested from microspheres after incuto a force versus strain curve. The results are expressed bation with citrate (50 µM). Cells were then centrifuas the average maximal mechanical force in grams from gated, resuspended with cultured medium, and then were at least five independent observations. The integrity of seeded on slices to perform immunocytology. the microparticles after the test was assessed by microscopic observation.
Immunocytology Cell Viability Assay
For in vitro differentiation, cells where stained with alizarin red or alcian blue coloration using standard The viability of encapsulated cells was assessed using a LIVE/DEAD Viability/Cytotoxicity kit (FluoProbes, methods. For chondrocyte detection, cells were incubated (1 h, RT) with an anti-PS100 rabbit antibody (1: France) for 35 days following microencapsulation. Briefly, microparticles were rinsed twice with phos-200, ABCYs, France). phate-buffered saline (PBS) and MEM (v/v). Microparticles were then incubated for 30 min with a solution con-Animal Transplantation and Histology taining 2 µM ethidium homodimer-3 and 1 µM calcein Experimental animals were handled in accordance AM. Microparticles were then rinsed with PBS and obwith the European animal care guidelines. Four Lewis served using a confocal microscope (Leica Microsysrats (Harlan, France) weighing 180-200 g were used for tems, Germany). Cell viability was determined from allogenic recipients of MSC-alginate. For transplantaconfocal images as previously described (26). After tion, rats were anesthetized with isoflurane/oxygen inhastaining, cells appear with red nuclei and lived cells with lation (3/97). A total of 18 microspheres containing 4 × green cytoplasm. Some population of MSCs exhibited 10 6 MSCs were transplanted under the renal capsule. apoptotic transformation so their nuclei looked yellow-Sham-operated animals were subjected to the same surorange, revealing the colocalization of fluorescence in gical procedure without transplantation. Kidney sections green and red spectral regions. The cell viability was were collected 25 days after MSC injection. estimated by the ratio of green pixels to the total number After euthanasia, kidneys were collected, fixed in of lightened pixels. paraformaldehyde (4%), dehydrated, and then embedded in paraffin. Paraffin sections (10 µm) were stained with Western Blot hematoxylin/eosin. For Western blot (WB), MSCs were extracted of microspheres through an incubation with citrate (50 µM)
Statistical Analysis and centrifugation. Then MSC proteins were extracted from pelleted MSCs. WB analyses were performed with Results are expressed as mean ± SEM. Statistical comparison of the data was performed using the t-test samples normalized for protein concentration. Membranes were probed with anti-bFGF (1:500; Santa Cruz for comparison between two groups or one-way ANOVA and post hoc Tukey's test for comparison of more than Biotechnology, USA) or anti-ERK2 (1:1,000; Santa Cruz Biotechnology, USA) antibodies. Following sev-two groups. A value of p < 0.05 was considered significant. eral washes in Tris-buffered saline-Tween (0.2%), mem-
RESULTS
cles present an average diameter between 500 and 710 µm with alginate microspheres slightly bigger than mi-Morphology and Stability of the crocapsules. The examination showed that MSCs ap-Alginate Microparticles peared evenly distributed throughout the microparticles, Morphology and stability of two types of micropartiwhich remained stable in saline buffer and in culture cles, microspheres and microcapsules, were examined media over the study. using optical and electron microscopy. Under optical
In order to demonstrate that the microcapsules had a microscopy, all cell-loaded microparticles had a uniform liquefied core, intact microparticles were dried and then and spherical morphology (Fig. 1A, B) . Concerning miobserved by electron microscopy (Fig. 1C, D) . In these crocapsules (Fig. 1B) , a smooth refringent ring, correconditions, microcapsules appeared no longer spherical, sponding to the continuous transparent alginate-PLL as they would appear if they had a solid core, but flatmembrane, could be observed. All of these micropartitened with a highly wrinkled surface (Fig. 1D ). Because they became fragile upon drying, some of them were broken, clearly showing that initial capsules were hollow and only constituted of a membrane surrounding a liquefied core.
Mechanical Resistance
In order to complete the study of microparticle morphology and stability, we determined their mechanical resistance. The resistance and durability of the microparticles were studied by submitting them to a standardized mechanical stress (28). This resistance to compression protocol is derived from the method of Orive et al. (3, 31) . The authors demonstrated that this technique permits differentiation among solid particles in order to choose the most resistant internal configuration. Moreover, it can be applied to both microcapsules and microspheres. Figure 1E shows the evolution of the maximal mechanical force (g) required to compress the beads of 30% of their height with time. In all cases, until day 35 postencapsulation, resistance to compression of microparticles remained stable. As expected, forces required to compress microspheres are higher than microcapsules, although the latter exhibited a more elastic behavior.
These results show that mechanical resistance of the two types of microparticles was unchanged with time (until day 35). In contrast, their mechanical behavior appeared quite different and could play a role in microparticle behavior postimplantation. Although they support small deformations, microcapsules remain prone to membrane disruption, while microspheres are mechanically stronger: their use would obviously increase the durability of the transplant and improve the feasibility of its retrieval. Microparticles were stained with ethidium homodimer-MESENCHYMAL STEM CELLS IN ALGINATE MICROSPHERES 1627 3 and calcein followed by 3D reconstitutions performed have shown that bFGF mediates part of the paracrine effects of MSCs (25 ) . We examined the production of using confocal microscopy. The viability of MSCs was quantified by automatic cell counting. This quantifica-bFGF in microencapsulated MSCs 7 days postencapsulation ( Fig. 3 ). Results showed that bFGF remains de-tion shows that viability of MSCs was poorly affected in microspheres ( Fig. 2A, D , green cytoplasm) until day tectable in microencapsulated MSCs and the amount of protein was not significantly different from that of non-35 (85.6 ± 4.8%) whereas it significantly decreased (64.6 ± 3.4%, 49.3 ± 4.9% on day 5 and 35, respec-encapsulated MSCs. These results indicated that, as showed for cultured MSCs, viable microencapsulated tively) in microcapsules (Fig. 2B, D) . These results led us to select microspheres rather than microcapsules for MSCs are able to produce bFGF. the next steps of our study.
In Vitro Viability of Encapsulated MSCs

In Vitro Differentiation of Microencapsulated MSCs In Vitro Functionality of Encapsulated MSCs
Some studies have investigated the possible differenin Microspheres tiation of matrix encapsulated MSCs into mesodermal lineages and more particularly into the chondrogenic and Several studies have shown that MSCs are able to secrete a number of cytokines, which may explain their osteogenic phenotypes. We compared the degree of chondrogenic differentiation of MSCs harvested from beneficial effects. Among these factors, we and others cell densities. Nevertheless, bFGF production was increased in higher concentrated microspheres. These results led us to choose higher concentrated microspheres for our study.
Implantation of Microencapsulated MSCs in Rats
As we have observed that microspheres are less elastic than microcapsules, we have evaluated the feasibility of manipulating and implanting microspheres at the surface of solid organ without degradation. Therefore, we have developed a model based on a deposition of microspheres under the renal capsule (Fig. 6A) . Optical observations showed that microspheres are still intact and did not migrate out of the renal capsule 25 days after graft (Fig. 6B ). Analysis of histological preparations stained with hematoxilin/eosin coloration showed detectable MSCs in microspheres 25 days after graft (Fig. 6C , dark arrow). No evidence of malignant invasion or inflammation was found in any of the specimens; however, longterm follow-up data are missing. We observed an accumulation of cells around microspheres with histological characteristics of a scar formation in the area under the renal capsule, but not in the cortical zone. This is in agreement with others results (22) and suggests that morphological characteristics of the renal parenchyma were not altered. Moreover, no fibrosis formation was observed around the microspheres (data not shown). In order to evaluate the effect of the graft on renal function, sham rats (Fig. 6D ). Results indicated that no significant the histogram shows the ratio of bFGF/ERK2. differences could be observed between the two groups until day 25 postgraft. Altogether, these results indicate that microspheres may be manipulated and grafted onto a solid organ, for a long period, without any significant microspheres (4 × 10 6 million MSCs/ml alginate) to MSC growth in chondroinductive medium. Results degradation or impairment of the renal function. showed that in all conditions, MSCs extracted from mi-DISCUSSION crospheres at 21, 31, 51, 56, and 61 days after encapsulation and replaced in culture were negative for alcian Microencapsulation of cells could be a promising strategy to improve cell survival after graft on solid or-blue staining (Fig. 4A ) nor labeled for PS100 (Fig. 4B ). Furthermore, 56 days after encapsulation and growth gan. Indeed, it allows avoiding intraparenchymal injection of cells, protecting them from mechanical stress, into standard medium, MSCs extracted from microspheres were also negative for alizarin red (Fig. 4C) (14, 42) . According with this observation, we have verified whether cell density has an crocapsules prepared with purified M alginate remained free of any significant foreign body response for pro-impact on MSC viability, functionality, and differentiation in alginate microspheres. In a first step, we pro-longed periods of time after implantation (6), while microcapsules prepared with high-G alginate were consis-duced alginate microspheres with 2.5 × 10 6 or 4 × 10 6 MSCs/ml of alginate (Fig. 5) . Results showed no differ-tently associated with low recovery rates and extensive overgrowth of inflammatory cells. ences in viability and in differentiation between the two Another parameter that could be modulated is the ity that can be applied to cell immobilization. The challenge is therefore not to increase stability but to de-type of microparticle used. Depending on encapsulation process, various mechanical and mass transport proper-termine what mechanical resistance is required for a specific application without changing other relevant particle ties of alginate microparticles should be obtained, both influencing scaffold integrity upon implantation and characteristics (5, 46) . According to microparticle permeability, the relation between tissular environment and cells viability and functionality. APA microcapsules with a liquefied inner core, pioneered by Lim and Sun encapsulated cells could be modified (50) . However, APA microcapsule cut-off is generally reported to be (20), have been the most frequently employed devices to transplant biomaterials to the host in the absence of between 60 and 90 kDa (4), while the absence of membrane in microspheres enables an open macroporosity, immunosuppression. However the long-term in vivo success of APA microcapsules has been limited, princi-permitting higher molecular weight molecules to diffuse (45) . pally due to the mechanical fragility of the membrane complex and to the difficult handling. Alginate micro-In this study, we investigated both microcapsules and microspheres in order to define the most suitable for en-spheres are expected to be stronger, obviously increasing the durability of the transplant and improving the capsulation of MSCs before grafting. Our results showed that they presented differences in their morphologies and feasibility of its retrieval. But there is still an open question related to the optimal conditions during the forma-their mechanical resistance but both remained stable over time. Moreover, our results indicated that micro-tion of mechanically stable particles with defined poros-spheres were associated with a higher survival rate of Altogether these results present an interest for future clinical approaches as microspheres are easier to obtain MSCs when compared to microcapsules. The higher survival of MSCs in microspheres could be explained by than microcapsules and would consequently facilitate a patient's graft. In order to evaluate functionality of en-their need of adherence, as they are immobilized in the alginate matrix while they are in suspension in micro-capsulated MSCs we measured MSC viability and the expression of bFGF, which is one of most abundant cy-capsules. However, a deleterious influence of capsule membrane cut-off cannot be excluded. Furthermore, tokines secreted by MCSs (25) . Indeed, bFGF is an angiogenic and mitogenic factor that has been previously in-Tam et al. have showed that the extent of immunoglobulin adsorption on alginate microcapsules was highly de-volved in renal protection and repair, mainly by stimulating angiogenesis and regeneration of renal cells pendent on the presence of the polylysine membrane, indicating that positive charges of the polycation are (9, 47) . The fact that encapsulated MSCs are still functional in these microspheres is important because benefi-mainly responsible for the binding of immunoglobulin (35, 43) . Because IgG, IgM, and IgA are known to be cial effects of MSCs are mainly due to their paracrine activity (54) . opsonizing proteins that lead to complement activation upon their adsorption to foreign surfaces, we decided to
The last unknown data remained their ability to be grafted on solid organs. In a recent study, RGD-alginate proceed with alginate microspheres. microspheres were grafted in bone (11) but nothing is nate molecular weight and consecutive biodegradability to obtain cells release in the purpose of tissue engi-known about their graft at the surface of solid organs like the heart or kidney. Another study has shown that neering. Encapsulating MSCs in alginate microspheres would intramyocardial injection of microcapsules could be done (52, 56) , but we have preferred avoiding intrapar-be a promising approach to improve cell survival after their graft in a solid organ. However, concerning the enchymal graft and the consecutive mechanical stress imposed to cells. So, we developed a protocol based heart, it could be difficult to implant microspheres. Recent studies have proposed to use patches to repair in-on the graft of microspheres under the renal capsule (37) . This site has been chosen as we have previously farcted cardiac tissue (2, 18, 30, 34, 39, 51) . In our laboratory, we have already showed that intramyocardial graft showed that MSC administration could have beneficial effects on kidney recovery, in a model of renal ische-of pharmacologically modified MSCs improves cardiac function (24). To further enhance MSC viability after mia-reperfusion, through a paracrine activity (25) . Furthermore, this graft site has already been validated for graft and consequently MSC efficiency it could be interesting to combine the easiness of engineering highly the transplantation of encapsulated pig islets with a better biocompatibility than for the intraperitoneal biocompatible alginate scaffolds with beneficial effects of MSCs. route (8) .
Our in vivo approach shows that it is possible to graft microspheres and to follow them during several weeks 
